Moreover, microglia contribute to the pathogenesis of AD through the glycolysis/H4K12la/PKM2 (pyruvate kinase M2) positive feedback loop (Zhao and Xu, 2022), highlighting this pathway as a potential target for pharmacological intervention. The gene discussed is PKM; the disease is Alzheimer disease.